Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Acute Graft-Versus-Host Disease
.
Show all posts
Showing posts with label
Acute Graft-Versus-Host Disease
.
Show all posts
Wednesday, October 2, 2019
FDA Approves Jakafi (ruxolitinib) for the Treatment of Patients with Acute Graft-Versus-Host Disease
›
In continuation of my update on ruxolitinib Incyte Corporation announced that the U.S. Food and Drug Administration (FDA...
›
Home
View web version
